China Resources Pharmaceutical (03320.HK): China Resources Pharmaceutical Commercial's net profit attributable to parent for the first three quarters was 1.42 billion yuan, up 5.62% year on year.

Zhitong Finance APP News: China Resources Pharmaceutical (03320.HK) announced that its non-wholly-owned subsidiary China Resources Pharmaceutical Commercial Group Co., Ltd. (China Resources Pharmaceutical Commercial) recorded operating revenue of RMB 169.46 billion (the same below) for the nine months ended September 30, 2026, up 2.64% year on year; net profit attributable to owners of the parent company was RMB 1.42 billion, up 5.62% year on year.